TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TARA

Protara Therapeutics Inc

Healthcare · Biotechnology

3.40$ -5.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Protara Therapeutics Inc (TARA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 176 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TARA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
49 44 36 34 49 44 39 28 27 24 18 12 53 7.0 70 63 199 203 192 189 181 173 161 155 149 113 106 95 88 79 68 102 94 181 169 157 145 209 192 176
49 43 35 33 48 43 38 28 27 23 5.5 11 42 7.0 40 33 167 169 88 88 96 93 91 101 99 86 95 84 78 69 58 92 85 172 127 125 136 160 140 146
27 36 34 18 20 21 25 12 18 19 -5.5 11 42 6.2 36 30 166 169 58 47 41 36 25 34 47 24 21 34 34 40 52 90 52 163 91 31 13 50 15 17
47 41 34 32 47 42 37 26 26 22 5.5 11 42 6.2 36 30 166 169 84 85 94 91 88 98 96 84 87 80 74 66 55 90 81 170 124 122 133 156 136 17
0.3 – – 0.3 0.3 – – – 0.1 – – – – – – – – – – – – 0.6 0.5 0.5 0.4 0.5 0.5 0.3 0.3 0.2 0.0 – – – 0.4 0.9 1.0 1.3 1.5 –
– – – – – – – – – – – – – – – – – – – – – 1.2 2.6 -0.5 – 1.2 -0.5 3.6 -0.3 – – – – – – – – – – –
0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.1 0.1 0.4 – 0.7 0.7 1.2 1.2 1.5 9.4 9.1 8.9 8.6 8.4 8.2 7.9 1.5 7.3 – – – – – – – – – – – –
– – – – – – – – – – – – 10.0 – 29 29 29 30 30 30 30 30 30 30 30 0.0 – – – – – – – – – – – – – –
– – – – – – – – – – – – 0.3 – – – – – 30 30 – – – 30 30 0.1 – – – 2.7 2.6 2.6 2.5 3.2 3.1 3.0 3.0 2.9 5.9 5.8
4.9 5.1 3.0 4.1 9.1 9.2 9.0 2.2 2.5 3.1 3.4 2.1 0.7 0.6 5.4 3.8 4.3 3.9 4.3 10 10 11 9.0 9.4 9.4 11 12 9.9 12 11 9.7 9.6 12 14 10 13 12 13 11 15
4.9 5.1 3.0 4.1 9.1 9.2 9.0 2.2 2.5 3.1 3.4 2.1 0.7 0.6 5.0 3.4 3.9 2.9 3.3 3.7 3.7 4.3 2.9 3.5 3.7 5.7 6.4 4.9 6.8 6.1 5.5 5.6 8.6 11 7.0 9.8 9.9 11 8.9 13
– – – – – – – – – – 0.1 0.1 – – 1.3 1.0 0.4 0.1 0.1 0.8 0.8 0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 1.0 1.0 1.0 1.1 1.1 1.2 1.2 1.2 1.2 1.3 1.3
0.6 0.6 0.5 1.2 0.2 0.3 7.0 0.4 0.4 0.4 1.7 0.1 0.1 0.3 2.6 0.9 1.9 0.9 1.9 1.4 0.9 1.0 0.5 0.4 0.5 1.6 4.1 1.9 2.5 2.4 1.0 1.4 2.3 4.4 2.3 5.3 4.5 3.5 4.0 4.7
45 38 33 29 39 35 29 26 25 20 4.8 9.5 52 6.4 65 59 195 199 188 178 170 162 152 145 139 102 95 85 77 68 58 92 82 167 158 144 132 196 181 161
-153 -160 -166 -172 -184 -190 -196 -201 -205 -210 -217 -222 -11 -225 -23 -30 -38 -47 -60 -73 -84 -94 -105 -113 -121 -160 -169 -180 -190 -200 -211 -221 -232 -245 -257 -272 -285 -302 -320 -342
0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 2.6 2.6 2.6 5.6 5.6 5.8 6.3 11 11 11 11 11 11 11 11 11 11 11 11 11 11 21 22 26 41 42 42 46 58 61

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?